drugset / Trial / NCT04627831
Comparison of Captisol-Enabled™ Iohexol and Omnipaque™ in Patients With Impaired Renal Function Undergoing Coronary Angiography
RandomizedParallel-groupQuadruple-blindPrevention
Summary
Randomized parallel group study comparing the renal safety of Captisol-Enabled™ Iohexol (CE-Iohexol) Injection and Omnipaque™ (Iohexol) Injection in patients with impaired renal function undergoing coronary angiography.
Timeline
- Start
- 2022-01
- Primary completion
- 2023-03
- Completion
- 2023-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | CE-Iohexol | Diagnostic / imaging agent | — | — |
| Comparator | Iohexol | Diagnostic / imaging agent | — | — |
Indications
No indication recorded.